Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5574516 | 1.00 | SOAT1 (0.50) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL29422232 | 1.00 | SOAT1 (0.50) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL28984571 | 1.00 | SOAT1 (0.50) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL1864976 | 0.90 | FAAH (0.69) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL2335481 | 0.90 | FAAH (0.69) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL29637717 | 0.87 | GPR84 (0.50) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL28925137 | 0.82 | SOAT1 (0.48) | SOAT1MEN1KMT2AFAAHTP53 | |
| SCHEMBL17272316 | 0.82 | GPR84 (0.58) | MEN1KMT2AGPR84PPARGPPARD | |
| SCHEMBL29037394 | 0.82 | GPR84 (0.58) | MEN1KMT2AGPR84PPARGPPARD | |
| SCHEMBL2052582 | 0.82 | GPR84 (0.58) | MEN1KMT2AGPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122055374-A | Lipid compounds and compositions for tissue-specific delivery of active substances | 韩国生命工学研究院 | 2026-05-15 | — | — | CN | claimed |
| CN-119661831-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4326235-A2 | CATIONIC LIPIDS AND COMPOSITIONS THEREOF | Generation Bio Co. (US) | 2024-02-28 | — | — | EP | claimed |
| CN-115957187-A | Lipid nanoparticle composition and drug delivery system prepared from same | 北京启辰生生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-119661831-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-115484932-B | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2024-12-10 | — | — | CN | disclosed |
| WO-2024151673-A2 | RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-07-18 | — | — | WO | disclosed |
| WO-2024151687-A1 | GENETIC SWITCHES AND THEIR USE IN TREATING CANCER | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| WO-2024151685-A1 | RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-4399307-A2 | HBB-MODULATING COMPOSITIONS AND METHODS | Flagship Pioneering Innovations VI, LLC (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-4399309-A2 | SERPINA-MODULATING COMPOSITIONS AND METHODS | Flagship Pioneering Innovations VI, LLC (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-4399306-A2 | PAH-MODULATING COMPOSITIONS AND METHODS | Flagship Pioneering Innovations VI, LLC (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2010057150-A1 | RELEASABLE POLYMERIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | ENZON PHARMACEUTICALS, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| EP-2131848-A2 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALY ACTIVE MOLECULES | Merck & Co., Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| EP-2104740-A2 | LIPID NANOPARTICLE BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | Sirna Therapeutics, Inc. (US) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008147438-A2 | LIPID NANOPARTICLE BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | SIRNA THERAPEUTICS, INC. (US) | 2008-12-04 | — | — | WO | disclosed |
| WO-2008103276-A2 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALY ACTIVE MOLECULES | MERCK & CO., INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| EP-1922300-A2 | CATIONIC LIPIDS AND FORMULATED MOLECULAR COMPOSITIONS CONTAINING THEM | Sirna Therapeutics Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| WO-2007086883-A2 | CATIONIC LIPIDS AND FORMULATED MOLECULAR COMPOSITIONS CONTAINING THEM | SIRNA THERAPEUTICS, INC. (US) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007086881-A2 | CATIONIC LIPIDS AND FORMULATED MOLECULAR COMPOSITIONS CONTAINING THEM | SIRNA THERAPEUTICS, INC. (US) | 2007-08-02 | — | — | WO | disclosed |